- Home
- Publications
- Publication Search
- Publication Details
Title
High-Risk Leukemia: Past, Present, and Future Role of NK Cells
Authors
Keywords
-
Journal
Journal of Immunology Research
Volume 2018, Issue -, Pages 1-12
Publisher
Hindawi Limited
Online
2018-04-16
DOI
10.1155/2018/1586905
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Natural killer cell-mediated immunosurveillance of human cancer
- (2017) Karl-Johan Malmberg et al. SEMINARS IN IMMUNOLOGY
- Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
- (2017) Congcong Zhang et al. Frontiers in Immunology
- Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation
- (2016) Brian C. Shaffer et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial
- (2016) Dean A. Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- TCR-alpha/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia
- (2016) M Maschan et al. BONE MARROW TRANSPLANTATION
- IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
- (2016) D. A. Vallera et al. CLINICAL CANCER RESEARCH
- Expanded and armed natural killer cells for cancer treatment
- (2016) Noriko Shimasaki et al. CYTOTHERAPY
- Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
- (2016) Rizwan Romee et al. Science Translational Medicine
- Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients
- (2015) P Lang et al. BONE MARROW TRANSPLANTATION
- Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells
- (2015) L. Ruggeri et al. HAEMATOLOGICA
- Natural killer cell therapy in children with relapsed leukemia
- (2015) Jeffrey E. Rubnitz et al. PEDIATRIC BLOOD & CANCER
- Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells
- (2015) L. Ruggeri et al. HAEMATOLOGICA
- Donor-Derived Natural Killer Cells Infused after Human Leukocyte Antigen–Haploidentical Hematopoietic Cell Transplantation: A Dose-Escalation Study
- (2014) Inpyo Choi et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL
- (2014) L. Oevermann et al. BLOOD
- HLA-haploidentical stem cell transplantation after removal of + T and B cells in children with nonmalignant disorders
- (2014) A. Bertaina et al. BLOOD
- Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells
- (2014) G. F. Torelli et al. HAEMATOLOGICA
- CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia
- (2013) M. L. Green et al. BLOOD
- Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies
- (2013) H. E. Kohrt et al. BLOOD
- Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16 x 33 Bispecific Killer Cell Engager and ADAM17 Inhibition
- (2013) A. Wiernik et al. CLINICAL CANCER RESEARCH
- Human NK cells and NK receptors
- (2013) Francesca Bellora et al. IMMUNOLOGY LETTERS
- At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies
- (2013) Franco Locatelli et al. JOURNAL OF LEUKOCYTE BIOLOGY
- At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias
- (2013) Håkan Norell et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells
- (2013) Hua Jiang et al. Molecular Oncology
- Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells
- (2013) Franco Locatelli et al. Frontiers in Immunology
- A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
- (2012) N. Vey et al. BLOOD
- Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
- (2012) M Stern et al. BONE MARROW TRANSPLANTATION
- Bispecific and Trispecific Killer Cell Engagers Directly Activate Human NK Cells through CD16 Signaling and Induce Cytotoxicity and Cytokine Production
- (2012) M. K. Gleason et al. MOLECULAR CANCER THERAPEUTICS
- HLA-C–Dependent Prevention of Leukemia Relapse by Donor ActivatingKIR2DS1
- (2012) Jeffrey M. Venstrom et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Approaches to Graft Engineering for Haploidentical Bone Marrow Transplantation
- (2012) Rupert Handgretinger SEMINARS IN ONCOLOGY
- Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
- (2011) A. Curti et al. BLOOD
- Human NK receptors: From the molecules to the therapy of high risk leukemias
- (2011) Lorenzo Moretta et al. FEBS LETTERS
- Natural Killer Cell-Enriched Donor Lymphocyte Infusions from A 3-6/6 HLA Matched Family Member following Nonmyeloablative Allogeneic Stem Cell Transplantation
- (2010) David A. Rizzieri et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
- (2010) S. Cooley et al. BLOOD
- Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation
- (2010) L. Moretta et al. BLOOD
- NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
- (2010) Jeffrey E. Rubnitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
- (2009) F. Romagne et al. BLOOD
- Generation of donor natural killer cells from CD34+ progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study
- (2009) S R Yoon et al. BONE MARROW TRANSPLANTATION
- Improving cord blood transplantation in children
- (2009) Franco Locatelli BRITISH JOURNAL OF HAEMATOLOGY
- The extensive polymorphism of KIR genes
- (2009) Derek Middleton et al. IMMUNOLOGY
- NK cell education: not an on-off switch but a tunable rheostat
- (2009) Petter Brodin et al. TRENDS IN IMMUNOLOGY
- Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity
- (2008) D. Pende et al. BLOOD
- Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor
- (2008) M. Stern et al. BLOOD
- Negative signaling by inhibitory receptors: the NK cell paradigm
- (2008) Eric O. Long IMMUNOLOGICAL REVIEWS
- Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation
- (2008) Andrea Velardi et al. Seminars in Immunopathology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search